Laurence of Oakland Inc

Castle Hill Holdings, Inc. is a North American holding company established in 1987, with a diverse portfolio that includes strategic businesses in real estate, energy, food and convenience stores, telecommunications, healthcare, and maritime ship repair yards. With a presence in the United States, Latin America, Europe, and the Pacific Rim, the firm offers flexibility to act as a Sponsor, Co-GP, and Investor across various industries. The founders of Castle Hill Holdings have been instrumental in pioneering significant changes in healthcare distribution and management in the United States, particularly through managed care programs such as HMOs and PPOs. Their focus on controlling channels of distribution enables the firm to engage in a wide range of transactions and investments, driving growth and innovation across its operations. Generated from the website

Omni Mask LLC is a company based in Lafayette, CA that specializes in the production and distribution of innovative facial protection solutions. Their products are designed to meet the needs of a diverse range of industries and individuals seeking reliable and comfortable face masks. With a focus on quality and functionality, Omni Mask LLC aims to provide effective solutions for everyday use and specific requirements. Their commitment to customer satisfaction and safety drives their continuous efforts in developing and delivering reliable protective gear. Generated from their business information

ExThera Medical Corporation, based in Martinez, CA, is a pioneering medical device company that specializes in developing innovative therapies for critical care patients. Their flagship product, the Seraph 100 Microbind Affinity Blood Filter, is a groundbreaking hemoperfusion technology designed to address unmet clinical needs in the treatment of severe COVID-19 and bloodstream infections. With a focus on pathogen absorption and blood purification, ExThera Medical is at the forefront of providing advanced solutions for patients in critical conditions. Additionally, ExThera Medical has launched the OncoBind Extracorporeal Procedure Program, an investigational device exemption (IDE) study aimed at treating metastatic cancer patients. This program showcases their commitment to developing cutting-edge therapies that have the potential to revolutionize cancer treatment. Through their dedication to innovation and patient care, ExThera Medical is making significant strides in improving outcomes for critically ill individuals.Generated from the website